Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications.

biomarkers blood brain cerebrospinal fluid crosstalk mass spectrometry neurodegenerative diseases post-translational modifications proteoforms

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
09 04 2022
Historique:
received: 14 03 2022
revised: 01 04 2022
accepted: 06 04 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 27 4 2022
Statut: epublish

Résumé

Neurodegenerative diseases are incurable, heterogeneous, and age-dependent disorders that challenge modern medicine. A deeper understanding of the pathogenesis underlying neurodegenerative diseases is necessary to solve the unmet need for new diagnostic biomarkers and disease-modifying therapy and reduce these diseases' burden. Specifically, post-translational modifications (PTMs) play a significant role in neurodegeneration. Due to its proximity to the brain parenchyma, cerebrospinal fluid (CSF) has long been used as an indirect way to measure changes in the brain. Mass spectrometry (MS) analysis in neurodegenerative diseases focusing on PTMs and in the context of biomarker discovery has improved and opened venues for analyzing more complex matrices such as brain tissue and blood. Notably, phosphorylated tau protein, truncated α-synuclein, APP and TDP-43, and many other modifications were extensively characterized by MS. Great potential is underlying specific pathological PTM-signatures for clinical application. This review focuses on PTM-modified proteins involved in neurodegenerative diseases and highlights the most important and recent breakthroughs in MS-based biomarker discovery.

Identifiants

pubmed: 35455959
pii: cells11081279
doi: 10.3390/cells11081279
pmc: PMC9031030
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Nat Med. 2020 Mar;26(3):398-407
pubmed: 32161412
Front Immunol. 2022 Jan 31;13:828648
pubmed: 35173739
Nat Cell Biol. 2002 Feb;4(2):160-4
pubmed: 11813001
Database (Oxford). 2021 Apr 7;2021:
pubmed: 33826699
Cells. 2020 Dec 08;9(12):
pubmed: 33302607
Nat Med. 2021 Jun;27(6):954-963
pubmed: 34083813
Nature. 2016 Nov 09;539(7628):179
pubmed: 27830810
Rapid Commun Mass Spectrom. 2015 Mar 30;29(6):461-73
pubmed: 26160412
Int J Mol Sci. 2015 Dec 02;16(12):28566-81
pubmed: 26633379
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32725127
J Alzheimers Dis. 2019;71(3):979-991
pubmed: 31450505
Nature. 2016 Nov 09;539(7628):207-216
pubmed: 27830778
Nat Chem Biol. 2008 Aug;4(8):483-90
pubmed: 18587388
J Proteome Res. 2016 Feb 5;15(2):667-76
pubmed: 26742856
Lancet Neurol. 2016 Jun;15(7):673-684
pubmed: 27068280
Nature. 2017 Jul 13;547(7662):185-190
pubmed: 28678775
Anal Chem. 2016 Apr 5;88(7):3704-14
pubmed: 26877193
J Neurosci. 2010 Mar 3;30(9):3184-98
pubmed: 20203178
Arch Neurol. 1999 Jun;56(6):673-80
pubmed: 10369305
Mol Cell Proteomics. 2021;20:100129
pubmed: 34339852
Cell. 2020 Feb 20;180(4):633-644.e12
pubmed: 32032505
Proteomics Clin Appl. 2015 Apr;9(3-4):307-21
pubmed: 25504613
Front Neurol. 2020 Jun 25;11:560
pubmed: 32670183
Sci Data. 2020 Sep 28;7(1):315
pubmed: 32985496
Circ Res. 2018 Apr 27;122(9):1221-1237
pubmed: 29700069
Annu Rev Neurosci. 2001;24:1121-59
pubmed: 11520930
Proteomics. 2018 Oct;18(20):e1800108
pubmed: 30230243
Neurol Res Pract. 2019 Sep 16;1:35
pubmed: 33324900
J Chromatogr A. 2014 Nov 6;1372C:1-17
pubmed: 25465002
Neurochem Int. 2011 Mar;58(4):458-71
pubmed: 21215781
Proteomics. 2009 Oct;9(20):4632-41
pubmed: 19743430
Nat Biotechnol. 2010 Aug;28(8):868-73
pubmed: 20639865
Nucleic Acids Res. 2015 Jan;43(Database issue):D512-20
pubmed: 25514926
Biomolecules. 2021 Jun 09;11(6):
pubmed: 34207636
Brain. 2020 Sep 1;143(9):2803-2817
pubmed: 32812023
Nat Rev Neurol. 2010 Mar;6(3):131-44
pubmed: 20157306
Neurosci Lett. 2000 May 5;285(1):49-52
pubmed: 10788705
Lancet Neurol. 2021 Jun;20(6):484-496
pubmed: 33933186
Annu Rev Pathol. 2011;6:193-222
pubmed: 21034221
Biochem Biophys Res Commun. 2006 Dec 22;351(3):602-11
pubmed: 17084815
Neuromolecular Med. 2013 Mar;15(1):169-79
pubmed: 23225274
N Engl J Med. 2001 May 17;344(20):1516-26
pubmed: 11357156
J Biol Chem. 2006 Apr 21;281(16):10825-38
pubmed: 16443603
Nature. 2016 Nov 09;539(7628):187-196
pubmed: 27830780
Nature. 2006 Oct 19;443(7113):780-6
pubmed: 17051204
Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4):
pubmed: 28716886
Nat Chem Biol. 2012 Feb 26;8(4):393-9
pubmed: 22366723
Nat Biotechnol. 2003 Mar;21(3):255-61
pubmed: 12610572
Biochemistry (Mosc). 2014 Dec;79(13):1515-27
pubmed: 25749162
Mol Cell Proteomics. 2021;20:100081
pubmed: 33862227
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6469-73
pubmed: 9600990
J Proteome Res. 2019 May 3;18(5):2109-2120
pubmed: 30943367
Neuron. 2010 Sep 23;67(6):953-66
pubmed: 20869593
J Neurochem. 1998 Dec;71(6):2465-76
pubmed: 9832145
Nat Protoc. 2013 Oct;8(10):1950-60
pubmed: 24051958
Neuropsychopharmacology. 2021 Jan;46(1):98-115
pubmed: 32898852
Nat Commun. 2020 Apr 3;11(1):1683
pubmed: 32246036
Trends Biochem Sci. 2019 Nov;44(11):943-960
pubmed: 31296352
Brain Pathol. 2021 Jul;31(4):e12923
pubmed: 33300249
J Neurochem. 2021 Oct;159(2):292-304
pubmed: 32986846
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11848-53
pubmed: 21712440
J Mass Spectrom. 2012 May;47(5):591-603
pubmed: 22576872
J Cell Sci. 2004 Nov 15;117(Pt 24):5721-9
pubmed: 15537830
Int J Mol Sci. 2019 Sep 20;20(19):
pubmed: 31547024
Alzheimers Res Ther. 2020 May 13;12(1):56
pubmed: 32404143
Sci Data. 2018 Mar 13;5:180036
pubmed: 29533394
Science. 2001 May 25;292(5521):1552-5
pubmed: 11375494
Mol Cell. 2011 Oct 21;44(2):325-40
pubmed: 21906983
NeuroRx. 2004 Apr;1(2):213-25
pubmed: 15717022
Neurosci Lett. 2000 Jun 16;287(1):65-7
pubmed: 10841992
Lancet Public Health. 2022 Feb;7(2):e105-e125
pubmed: 34998485
Clin Proteomics. 2016 Jan 07;13:1
pubmed: 26751220
Sci Rep. 2016 Mar 16;6:23281
pubmed: 26980269
Biochim Biophys Acta. 2005 Jan 3;1739(2-3):198-210
pubmed: 15615638
Lancet Neurol. 2014 Jun;13(6):614-29
pubmed: 24849862
Nat Rev Neurosci. 2022 Jan;23(1):53-66
pubmed: 34815562
Ann Rheum Dis. 2020 Apr;79(4):472-480
pubmed: 32041746
Nat Biotechnol. 2003 Aug;21(8):921-6
pubmed: 12872131
Neurology. 2021 Apr 27;96(17):e2201-e2211
pubmed: 33722997
Sci Rep. 2014 Jul 23;4:5797
pubmed: 25052239
Front Aging Neurosci. 2021 Oct 27;13:765259
pubmed: 34776937
EMBO Mol Med. 2021 Dec 7;13(12):e15098
pubmed: 34725927
Proteomics. 2018 Sep;18(18):e1700309
pubmed: 29512899
Neurochem Res. 2004 Jun;29(6):1317-31
pubmed: 15176488
J Proteome Res. 2020 Mar 6;19(3):1310-1318
pubmed: 32101007
Int J Biochem Cell Biol. 2009 Nov;41(11):2134-46
pubmed: 19782947
J Biol Chem. 1995 Jan 13;270(2):823-9
pubmed: 7822317
Adv Exp Med Biol. 2016;919:345-382
pubmed: 27975226
Neuron. 2018 Mar 21;97(6):1284-1298.e7
pubmed: 29566794
Med Sci (Paris). 2003 Aug-Sep;19(8-9):865-72
pubmed: 14593619
FASEB J. 2003 Oct;17(13):1945-7
pubmed: 14519670
Brain. 2018 Jul 1;141(7):2181-2193
pubmed: 29878075
Front Neurosci. 2021 Feb 09;15:639140
pubmed: 33633540
Folia Neuropathol. 2020;58(2):93-112
pubmed: 32729289
J Am Soc Mass Spectrom. 2017 Jan 1;28(1):5-13
pubmed: 32020797
Trends Biotechnol. 1997 Oct;15(10):418-25
pubmed: 9351286
Acta Neuropathol. 2019 Feb;137(2):279-296
pubmed: 30547227
Alzheimers Res Ther. 2021 Dec 4;13(1):198
pubmed: 34863295
Nat Methods. 2007 Oct;4(10):817-21
pubmed: 17901871
Free Radic Biol Med. 2013 Dec;65:925-941
pubmed: 24002012
Nat Rev Mol Cell Biol. 2015 May;16(5):269-80
pubmed: 25857810
Biochem J. 2014 Aug 15;462(1):77-88
pubmed: 24869773
Hum Mol Genet. 2008 Feb 1;17(3):431-9
pubmed: 17981811
J Proteome Res. 2019 Oct 4;18(10):3770-3779
pubmed: 31437391
Mol Cell Proteomics. 2002 May;1(5):376-86
pubmed: 12118079
Mol Cell Proteomics. 2016 Oct;15(10):3126-3138
pubmed: 27507836
Alzheimers Res Ther. 2020 Mar 17;12(1):26
pubmed: 32183883
Pharmacol Ther. 2005 Mar;105(3):311-31
pubmed: 15737408
Expert Rev Proteomics. 2015;12(5):499-517
pubmed: 26400466
Proteomics Clin Appl. 2017 Jul;11(7-8):
pubmed: 28319654
Anal Chem. 2020 Jan 7;92(1):1525-1533
pubmed: 31825201
Nat Protoc. 2018 Jul;13(7):1632-1661
pubmed: 29988108
Neuron. 2006 Oct 5;52(1):33-8
pubmed: 17015225
Methods Enzymol. 2017;585:377-395
pubmed: 28109439
Biochim Biophys Acta. 2015 Jul;1854(7):705-17
pubmed: 25680928
Am J Pathol. 1998 Apr;152(4):879-84
pubmed: 9546347
Nature. 2016 Nov 10;539(7628):197-206
pubmed: 27830784
Sci Rep. 2015 Oct 29;5:15709
pubmed: 26511732
Alzheimers Res Ther. 2020 Feb 28;12(1):20
pubmed: 32111242
Expert Rev Proteomics. 2015 Jun;12(3):235-53
pubmed: 25955281
Nature. 2016 Nov 09;539(7628):180-186
pubmed: 27830812
Analyst. 2019 Oct 22;144(21):6342-6351
pubmed: 31553333
J Biol Chem. 1992 Aug 25;267(24):17047-54
pubmed: 1512244
Brain. 2017 Dec 1;140(12):3329-3345
pubmed: 29053860
Front Aging Neurosci. 2020 Nov 23;12:575481
pubmed: 33328957
FEBS Lett. 2001 May 11;496(2-3):152-60
pubmed: 11356201
Mol Chem Neuropathol. 1995 Dec;26(3):231-45
pubmed: 8748926
Anal Bioanal Chem. 2005 Jun;382(3):669-78
pubmed: 15900442
FASEB J. 2011 Dec;25(12):4127-37
pubmed: 21865317
Nat Med. 2015 Oct;21(10):1154-62
pubmed: 26390242
Cell. 2020 Dec 10;183(6):1699-1713.e13
pubmed: 33188775
Ann Clin Transl Neurol. 2019 Dec;6(12):2489-2502
pubmed: 31742901
Nat Methods. 2013 Mar;10(3):186-7
pubmed: 23443629
Chembiochem. 2020 Apr 17;21(8):1052-1079
pubmed: 31863723
Front Aging Neurosci. 2019 May 21;11:121
pubmed: 31178717
Biol Chem. 2019 Jun 26;400(7):895-915
pubmed: 30998500
Ageing Res Rev. 2021 Jul;68:101336
pubmed: 33775891
J Am Soc Mass Spectrom. 2003 Sep;14(9):957-70
pubmed: 12954164
Science. 2006 Oct 6;314(5796):130-3
pubmed: 17023659
Sci Rep. 2017 Aug 25;7(1):9520
pubmed: 28842697
Cold Spring Harb Perspect Med. 2012 Feb;2(2):a009399
pubmed: 22355802
Front Neurol. 2021 Jan 07;11:595532
pubmed: 33488497
Q Rev Biophys. 2011 Nov;44(4):467-518
pubmed: 21729349
Nat Rev Mol Cell Biol. 2010 Jun;11(6):427-39
pubmed: 20461098
J Biol Chem. 2006 Oct 6;281(40):29739-52
pubmed: 16847063
Anal Bioanal Chem. 2007 Oct;389(4):1017-31
pubmed: 17668192
Cell. 2020 Nov 25;183(5):1436-1456.e31
pubmed: 33212010

Auteurs

Rita Azevedo (R)

CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Université Paris-Saclay, 91191 Gif-sur-Yvette, France.

Chloé Jacquemin (C)

CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Université Paris-Saclay, 91191 Gif-sur-Yvette, France.

Nicolas Villain (N)

CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Université Paris-Saclay, 91191 Gif-sur-Yvette, France.
Institut du Cerveau (ICM), Pitié-Salpêtrière Hospital, 75013 Paris, France.
Department of Neurology, Institute of Memory and Alzheimer's Disease, Pitié-Salpêtrière Hospital, AP-HP Sorbonne Université, CEDEX 13, 75651 Paris, France.

François Fenaille (F)

CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Université Paris-Saclay, 91191 Gif-sur-Yvette, France.

Foudil Lamari (F)

Department of Metabolic Biochemistry (AP-HP Sorbonne), Pitié-Salpêtrière Hospital, CEDEX 13, 75651 Paris, France.

François Becher (F)

CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Université Paris-Saclay, 91191 Gif-sur-Yvette, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH